{"id":"https://openalex.org/W4400239571","doi":"https://doi.org/10.1158/1535-7163.26145069","title":"Supplementary Method S1 from A Bispecific Antibody That Targets the Membrane-Proximal Region of Mesothelin and Retains High Anticancer Activity in the Presence of Shed Mesothelin","display_name":"Supplementary Method S1 from A Bispecific Antibody That Targets the Membrane-Proximal Region of Mesothelin and Retains High Anticancer Activity in the Presence of Shed Mesothelin","publication_year":2024,"publication_date":"2024-07-02","ids":{"openalex":"https://openalex.org/W4400239571","doi":"https://doi.org/10.1158/1535-7163.26145069"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.26145069","doi":"https://doi.org/10.1158/1535-7163.26145069","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.26145069","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.26145069","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015234183","display_name":"Anirban Chakraborty","orcid":"https://orcid.org/0000-0002-5244-0599","observed_orcids":["https://orcid.org/0000-0002-5244-0599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anirban Chakraborty","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5244-0599","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086855365","display_name":"Masanori Onda","orcid":"https://orcid.org/0000-0002-6805-2152","observed_orcids":["https://orcid.org/0000-0002-6805-2152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masanori Onda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6805-2152","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Tara O\u2019Shea","orcid":"https://orcid.org/0000-0002-8955-6640","observed_orcids":["https://orcid.org/0000-0002-8955-6640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tara O\u2019Shea","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8955-6640","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005008349","display_name":"Junxia Wei","orcid":"https://orcid.org/0009-0009-8366-4657","observed_orcids":["https://orcid.org/0009-0009-8366-4657"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junxia Wei","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-8366-4657","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026114195","display_name":"Xiufen Liu","orcid":"https://orcid.org/0000-0002-7820-2783","observed_orcids":["https://orcid.org/0000-0002-7820-2783"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiufen Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7820-2783","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002583441","display_name":"Tapan Kumar Bera","orcid":"https://orcid.org/0000-0002-8779-4004","observed_orcids":["https://orcid.org/0000-0002-8779-4004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tapan K. Bera","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8779-4004","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056573254","display_name":"Ira H Pastan","orcid":"https://orcid.org/0000-0002-9223-0270","observed_orcids":["https://orcid.org/0000-0002-9223-0270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ira Pastan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9223-0270","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9879999756813049},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/membrane-proximal-region","display_name":"membrane-proximal region","score":0.9539999961853027},{"id":"https://openalex.org/keywords/antibody-preparation","display_name":"antibody preparation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7770000100135803},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C2777045440","wikidata":"https://www.wikidata.org/wiki/Q14914057","display_name":"Mesothelin","level":3,"score":0.995232880115509},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.5954613089561462},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3519080877304077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.201593279838562},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.17203757166862488},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12937158346176147}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.26145069","doi":"https://doi.org/10.1158/1535-7163.26145069","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.26145069","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.32710144","doi":"https://doi.org/10.1158/1535-7163.32710144","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.32710144","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/32710144","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Method_S1_from_A_Bispecific_Antibody_That_Targets_the_Membrane-Proximal_Region_of_Mesothelin_and_Retains_High_Anticancer_Activity_in_the_Presence_of_Shed_Mesothelin/32710144","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.26145069","doi":"https://doi.org/10.1158/1535-7163.26145069","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.26145069","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7165020901","https://openalex.org/W4400242194","https://openalex.org/W7164989740","https://openalex.org/W4394998644","https://openalex.org/W4400241215","https://openalex.org/W3012467468","https://openalex.org/W6888793860","https://openalex.org/W7216469133","https://openalex.org/W7148925531","https://openalex.org/W3090933723"],"abstract_inverted_index":{"Supplementary":[0],"Method":[1],"1":[2],"explains":[3],"the":[4],"preparation":[5],"of":[6],"BsAb":[7],"5.":[8]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-07-03T00:00:00"}